News / All News / Article

How Standout Startups Grow in the New Normal, and Reflections on Industry-Specific AI Applications: Renmin University of China Business School’s Venture Capital and Innovation Club Visits Weiming Penguin

Article images may contain Chinese text.



On June 28, more than 40 members of the Renmin University of China Business School MBA Venture Capital and Innovation Club visited Weiming Penguin’s discussion venue at the new Alibaba Chaoyang Technology Park campus in Beijing. They exchanged ideas on how standout startups grow in the new normal, as well as perspectives, practical experience, and innovative approaches to industry-specific AI applications. Weiming Penguin founder and CEO Zou Xiaoliang; co-founder and President Tian Ying; Wang Qiang, associate professor and doctoral supervisor at the Business School and deputy director of the Yunus Center; Wei Yawei, general manager for the healthcare industry at DingTalk; and Business School student representatives explored the challenges and joys of innovation and entrepreneurship together.


Image

Renmin University of China Business School’s Venture Capital and Innovation Club Visits Weiming Penguin


Since its establishment, the Renmin University of China Business School MBA Venture Capital and Innovation Club has provided room for imagination in innovation and given entrepreneurship wings to move forward. A registered alumni club of the Business School, it aims to “strengthen communication and collaboration among entrepreneurs, enrich their entrepreneurial knowledge and skills, expand their access to external resources, and increase their entrepreneurial achievements.” It is actively building a comprehensive platform serving MBA entrepreneurs at Renmin University of China. The club serves entrepreneurial MBA alumni of the Business School, as well as current students who are starting businesses or interested in doing so.


Image

The Visit and Discussion Session


At the discussion, Weiming Penguin founder and CEO Zou Xiaoliang delivered opening remarks that drew repeated applause. He said: “As a provider of digital solutions for the pharmaceutical and healthcare industries, Weiming Penguin has helped more than 100 pharmaceutical companies achieve digital transformation. Our clients include both domestic and foreign-invested pharmaceutical companies, and our customer satisfaction ranks among the best. Despite earning recognition from so many pharmaceutical clients, Weiming Penguin has not stopped there. In 2024, we have demonstrated a strong commitment to action in technological innovation and product upgrades. Specifically, we have invested substantial human and technical resources and upgraded our entire product lineup with AI technologies and digital intelligence capabilities.”


Image

Opening Remarks by Weiming Penguin Co-Founder and CEO Zou Xiaoliang


Weiming Penguin has been on its journey for eight years. As a startup focused on the healthcare industry, it has remained true to the aspirations with which it was founded. At the discussion, co-founder and President Tian Ying introduced the company’s core strengths, cultural values, and development story. She said: “Founded in November 2015, Weiming Penguin is committed to becoming a pioneer in big data technologies and solutions for China’s pharmaceutical and healthcare industries. As a leading provider of pharmaceutical digital intelligence solutions, we focus on addressing three key challenges companies face during digital transformation: whether data is available, how to use it, and how to manage the business. We help companies digitize their organizations and business operations and turn data into assets. Our core values are: customers first, openness and integrity, dedication, innovation, and collaboration.” Tian Ying also shared her journey from a major technology company to entrepreneurship. In her view, the traditional pharmaceutical industry presents both barriers and opportunities, and entrepreneurship means continually seeking areas where value can be improved. As an observer and innovator, she has found that entrepreneurship has added color to her life.


Image

Insights from Weiming Penguin Co-Founder and President Tian Ying


Wei Yawei, general manager for the healthcare industry at Alibaba’s DingTalk, shared DingTalk’s entrepreneurial history, along with perspectives and practical experience on AI applications in the pharmaceutical sector. He said: “AI enables new ways of working to break through productivity bottlenecks and will drive business growth. The key questions in the AI era are: Does it change how people interact? Is the barrier to entry low enough, and is it accessible enough to benefit everyone? Right now, we should be thinking about how to improve internal productivity and how to use AI tools to drive productivity growth. When a company grows rapidly, the capabilities of its people are the primary factor determining the upper limit of organizational development. In the pharmaceutical industry, an R&D professional who can converse skillfully with AI will become more capable at work, focus more actively on valuable tasks, and be more willing to contribute personally. Only by ‘AI-enabling how every employee works’ at the micro level, ‘AI-enabling core business operations’ at the organizational level, and ‘providing AI assistants to customers and upstream and downstream partners’ at the macro level can we put AI applications into practice and achieve breakthroughs, moving from basic to deep applications and then from depth to breadth. Looking ahead, we should not overestimate AI’s short-term value, and we certainly should not underestimate its long-term value.” In response to students’ concerns about how working professionals can avoid being replaced by AI technologies, Wei Yawei advised that actively learning and mastering AI technologies will be key to preparing for the future.


Image

Insights from Wei Yawei, General Manager for the Healthcare Industry at Alibaba’s DingTalk


During the panel discussion, Bian Shenghui, deputy general manager of Yunnan Botanee Bio-Technology Group Co., Ltd., compared the fast-moving consumer goods and pharmaceutical industries and summarized the three stages of digital development in the pharmaceutical industry. Gao Mingxu, vice president of Borui Biopharmaceutical, shared technological advances in digital intelligence-based decision-making, R&D planning, business process management, and related areas. Wang Yishen, a Business School student representative from the MBA FT1 class of the 2023 cohort, discussed investment trends and equity financing models in healthcare. Following the lively panel discussion and exchange, Professor Wang Qiang, an associate professor and doctoral supervisor at Renmin University of China Business School and deputy director of the Yunus Center, summarized the session.


Image

The Panel Discussion


Weiming Penguin warmly welcomed the members of the Renmin University of China Business School MBA Venture Capital and Innovation Club. This exchange of ideas across industries also brought fresh energy and new perspectives to the company. Throughout the visit, the discussions made complex topics accessible, moving from broad trends in innovation and entrepreneurship to practical experiences at individual companies and then to AI applications in the pharmaceutical and healthcare industries. Every session stayed closely focused on the theme, enabling students to gain a comprehensive, in-depth understanding of the many facets of innovation and entrepreneurship.


The guests’ presentations were packed with practical insights. Drawing on their personal experiences and successful cases, they revealed the challenges and joys of innovation and entrepreneurship and offered many useful suggestions and guidance. The event was hosted by Zhao Fei, a Weiming Penguin solutions expert and a member of Renmin University of China Business School’s 2016 MBA cohort. After the visit, the students also toured Alibaba’s new Beijing campus.


Image